66 related articles for article (PubMed ID: 33069615)
1. A new inflammatory-microthrombotic syndrome as an explanation for thrombotic complications in patients with COVID-19.
Valga F; Vega-Díaz N; Macía M; Rodríguez-Pérez JC
Rev Esp Cardiol (Engl Ed); 2021 Jan; 74(1):115-116. PubMed ID: 33069615
[No Abstract] [Full Text] [Related]
2. Increased Incidence of Tapia's Syndrome Cases Since the COVID-19 Pandemic.
Mat Q; Hamdar A; Mehta R
Ear Nose Throat J; 2024 Jun; 103(1_suppl):9S. PubMed ID: 34969313
[No Abstract] [Full Text] [Related]
3. Understanding factors influencing the length of hospital stay among non-severe COVID-19 patients: A retrospective cohort study in a Fangcang shelter hospital.
Wu S; Xue L; Legido-Quigley H; Khan M; Wu H; Peng X; Li X; Li P
PLoS One; 2020; 15(10):e0240959. PubMed ID: 33085709
[TBL] [Abstract][Full Text] [Related]
4. Specific Redistribution of Severe Acute Respiratory Syndrome Coronavirus 2 Variants in the Respiratory System and Intestinal Tract.
Du P; Song C; Li R; Song Y; Li J; Ding N; Zhang J; Song R; Han J; Gao G; Yue J; Duan A; Huang Y; An J; Wang J; Zhang F; Chen C; Zeng H
Clin Infect Dis; 2021 Nov; 73(9):e2814-e2817. PubMed ID: 33086379
[TBL] [Abstract][Full Text] [Related]
5. A pooled testing strategy for identifying SARS-CoV-2 at low prevalence.
Mutesa L; Ndishimye P; Butera Y; Souopgui J; Uwineza A; Rutayisire R; Ndoricimpaye EL; Musoni E; Rujeni N; Nyatanyi T; Ntagwabira E; Semakula M; Musanabaganwa C; Nyamwasa D; Ndashimye M; Ujeneza E; Mwikarago IE; Muvunyi CM; Mazarati JB; Nsanzimana S; Turok N; Ndifon W
Nature; 2021 Jan; 589(7841):276-280. PubMed ID: 33086375
[TBL] [Abstract][Full Text] [Related]
6. COVID-19, Hypercoagulability, and Cautiousness with Convalescent Plasma.
Sanfilippo F; La Rosa V; Oliveri F; Astuto M
Am J Respir Crit Care Med; 2021 Jan; 203(2):257-258. PubMed ID: 33085908
[No Abstract] [Full Text] [Related]
7. Age-related susceptibility to coronavirus infections: role of impaired and dysregulated host immunity.
Channappanavar R; Perlman S
J Clin Invest; 2020 Dec; 130(12):6204-6213. PubMed ID: 33085654
[TBL] [Abstract][Full Text] [Related]
8. COVID-19 Mortality Risk in Down Syndrome: Results From a Cohort Study of 8 Million Adults.
Clift AK; Coupland CAC; Keogh RH; Hemingway H; Hippisley-Cox J
Ann Intern Med; 2021 Apr; 174(4):572-576. PubMed ID: 33085509
[No Abstract] [Full Text] [Related]
9. Clinical features and antibody response of patients from a COVID-19 treatment hospital in Wuhan, China.
Chen Y; Ke Y; Liu X; Wang Z; Jia R; Liu W; Yang C; Jia L; Wang Y; Han L; Xia X; Zhang S; Wang C
J Med Virol; 2021 May; 93(5):2782-2789. PubMed ID: 33085103
[TBL] [Abstract][Full Text] [Related]
10. Commercial Serology Assays Predict Neutralization Activity against SARS-CoV-2.
Suhandynata RT; Hoffman MA; Huang D; Tran JT; Kelner MJ; Reed SL; McLawhon RW; Voss JE; Nemazee D; Fitzgerald RL
Clin Chem; 2021 Jan; 67(2):404-414. PubMed ID: 33084854
[TBL] [Abstract][Full Text] [Related]
11. A systematic review and meta-analysis of the use of renin-angiotensin system drugs and COVID-19 clinical outcomes: What is the evidence so far?
Kurdi A; Abutheraa N; Akil L; Godman B
Pharmacol Res Perspect; 2020 Dec; 8(6):e00666. PubMed ID: 33084232
[TBL] [Abstract][Full Text] [Related]
12. Is the outcome of SARS-CoV-2 infection in solid organ transplant recipients really similar to that of the general population?
Mendoza MA; Raja M; Villavicencio A; Anjan S; Natori Y
Am J Transplant; 2021 Apr; 21(4):1670-1671. PubMed ID: 33084171
[No Abstract] [Full Text] [Related]
13. Seroprevalence of anti-SARS-CoV-2 antibodies in COVID-19 patients and healthy volunteers up to 6 months post disease onset.
Figueiredo-Campos P; Blankenhaus B; Mota C; Gomes A; Serrano M; Ariotti S; Costa C; Nunes-Cabaço H; Mendes AM; Gaspar P; Pereira-Santos MC; Rodrigues F; Condeço J; Escoval MA; Santos M; Ramirez M; Melo-Cristino J; Simas JP; Vasconcelos E; Afonso Â; Veldhoen M
Eur J Immunol; 2020 Dec; 50(12):2025-2040. PubMed ID: 33084029
[TBL] [Abstract][Full Text] [Related]
14. Associations Between Genetically Predicted Protein Levels and COVID-19 Severity.
Zhu J; Wu C; Wu L
J Infect Dis; 2021 Jan; 223(1):19-22. PubMed ID: 33083826
[TBL] [Abstract][Full Text] [Related]
15. Predicting COVID-19 Severity with a Specific Nucleocapsid Antibody plus Disease Risk Factor Score.
Sen S; Sanders EC; Gabriel KN; Miller BM; Isoda HM; Salcedo GS; Garrido JE; Dyer RP; Nakajima R; Jain A; Caldaruse AM; Santos AM; Bhuvan K; Tifrea DF; Ricks-Oddie JL; Felgner PL; Edwards RA; Majumdar S; Weiss GA
bioRxiv; 2021 Mar; ():. PubMed ID: 33083803
[TBL] [Abstract][Full Text] [Related]
16. Prediction and mitigation of mutation threats to COVID-19 vaccines and antibody therapies.
Chen J; Gao K; Wang R; Wei G
ArXiv; 2021 Mar; ():. PubMed ID: 33083498
[TBL] [Abstract][Full Text] [Related]
17. Correlations between Meteorological Indicators, Air Quality and the COVID-19 Pandemic in 12 Cities across China.
Huang H; Liang X; Huang J; Yuan Z; Ouyang H; Wei Y; Bai X
J Environ Health Sci Eng; 2020 Dec; 18(2):1491-1498. PubMed ID: 33082960
[TBL] [Abstract][Full Text] [Related]
18. The Outcome of Hydroxychloroquine in Patients Treated for COVID-19: Systematic Review and Meta-Analysis.
Ayele Mega T; Feyissa TM; Dessalegn Bosho D; Kumela Goro K; Zeleke Negera G
Can Respir J; 2020; 2020():4312519. PubMed ID: 33082891
[TBL] [Abstract][Full Text] [Related]
19. Author Correction: SARS-CoV-2 Nsp1 binds the ribosomal mRNA channel to inhibit translation.
Schubert K; Karousis ED; Jomaa A; Scaiola A; Echeverria B; Gurzeler LA; Leibundgut M; Thiel V; Mühlemann O; Ban N
Nat Struct Mol Biol; 2020 Nov; 27(11):1094. PubMed ID: 33082564
[TBL] [Abstract][Full Text] [Related]
20. Expression of SARS-CoV-2 entry factors in lung epithelial stem cells and its potential implications for COVID-19.
Valyaeva AA; Zharikova AA; Kasianov AS; Vassetzky YS; Sheval EV
Sci Rep; 2020 Oct; 10(1):17772. PubMed ID: 33082395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
